Pulmonary hypertension and NO in sickle cell.
Gladwin
Mark T
MT
Barst
Robyn J
RJ
Castro
Oswaldo L
OL
Gordeuk
Victor R
VR
Hillery
Cheryl A
CA
Kato
Gregory J
GJ
Kim-Shapiro
Daniel B
DB
Machado
Roberto
R
Morris
Claudia R
CR
Steinberg
Martin H
MH
Vichinsky
Elliott P
EP
D000328:Adult; D000745:Anemia, Hemolytic, Congenital / Q000209:etiology / Q000503:physiopathology; D000755:Anemia, Sickle Cell / Q000097:blood / Q000150:complications / Q000401:mortality / Q000503:physiopathology*; D000818:Animals; D015415:Biomarkers; D006328:Cardiac Catheterization; D002986:Clinical Trials as Topic; D004195:Disease Models, Animal; D006801:Humans; D006976:Hypertension, Pulmonary / Q000175:diagnosis / Q000209:etiology* / Q000401:mortality / Q000503:physiopathology; D008297:Male; D051379:Mice; D020097:Natriuretic Peptide, Brain / Q000097:blood; D009569:Nitric Oxide / Q000097:blood / Q000172:deficiency* / Q000502:physiology; D010446:Peptide Fragments / Q000097:blood; D011317:Priapism / Q000209:etiology; D012307:Risk Factors; D017211:Treatment Failure; D014262:Tricuspid Valve Insufficiency / Q000000981:diagnostic imaging / Q000209:etiology / Q000503:physiopathology; D014463:Ultrasonography
D015415:Biomarkers; D010446:Peptide Fragments; C109794:pro-brain natriuretic peptide (1-76); D020097:Natriuretic Peptide, Brain; D009569:Nitric Oxide